SMER28 is a mTOR-independent small molecule enhancer of autophagy that protects mouse bone marrow and liver against radiotherapy
Effective cytoprotectors that are selective for normal tissues could decrease radiotherapy and chemotherapy sequelae and facilitate the safe administration of higher radiation doses. This could improve the cure rates of radiotherapy for cancer patients. Autophagy is a cytoplasmic cellular process th...
Main Authors: | Koukourakis, M, Giatromanolaki, A, Fylaktakidou, K, Sivridis, E, Zois, C, Kalamida, D, Mitrakas, A, Pouliliou, S, Karagounis, I, Simopoulos, K, Ferguson, D, Harris, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Springer
2018
|
Similar Items
-
Amifostine protects mouse liver against radiation-induced autophagy blockage
by: Koukourakis, M, et al.
Published: (2018) -
Autophagosome proteins LC3A, LC3B and LC3C have distinct subcellular distribution kinetics and expression in cancer cell lines
by: Koukourakis, M, et al.
Published: (2015) -
Normal tissue radioprotection by amifostine via Warburg-type effects.
by: Koukourakis, M, et al.
Published: (2016) -
Fever-range hyperthermia vs. hypothermia effect on cancer cell viability, proliferation and HSP90 expression.
by: Dimitra Kalamida, et al.
Published: (2015-01-01) -
SMER28 Attenuates PI3K/mTOR Signaling by Direct Inhibition of PI3K p110 Delta
by: Marco Kirchenwitz, et al.
Published: (2022-05-01)